There were also investigations about ERCC5 and lung cancer prognosis, ERCC5 (rs2094258 and rs2296147) was reported to be related to progression-free survival (PFS) in NSCLC patients treated with platinum-based chemotherapy [45]. Here, ERCC5 is linked to non-small cell lung carcinoma.